LifeStance Health (LFST) Operating Expenses (2020 - 2026)

LifeStance Health (LFST) has 7 years of Operating Expenses data on file, last reported at $381.2 million in Q1 2026.

• Quarterly Operating Expenses rose 15.04% year-over-year to $381.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 11.82% YoY) and the FY2025 annual result came in at $1.4 billion, up 9.17% from the prior year.
• Operating Expenses rose to $381.2 million in Q1 2026 per LFST's latest filing, from $364.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $381.2 million in Q1 2026 and bottomed at $256.4 million in Q3 2022.
• The 5-year median for Operating Expenses is $317.2 million (2024), against an average of $316.4 million.
• Peak annual rise in Operating Expenses reached 86.06% in 2022, while the deepest fall reached 14.11% in 2022.
• Tracing LFST's Operating Expenses over 5 years: stood at $275.4 million in 2022, then climbed by 13.62% to $312.9 million in 2023, then rose by 3.69% to $324.4 million in 2024, then advanced by 12.23% to $364.1 million in 2025, then gained by 4.69% to $381.2 million in 2026.
• Per Business Quant, the three latest LFST Operating Expenses figures stand at $381.2 million (Q1 2026), $364.1 million (Q4 2025), and $356.4 million (Q3 2025).

Peer Comparison